Brian Marckx, CFA
Long/short equity

Revenue Hit From Loss Of Manufacturing Customer But Recent Sell-Off Overdone

BioLife Solutions (NASDAQ:BLFS) announced results for Q1 2014. Revenue of $2.1M was about 4% lower yoy although excluding $609k in non-recurring licensing revenue booked in Q1 2013, total revenue growth was 33%. Even more importantly growth in product revenue, which will be the long-term driver of the top-line (as ...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.